Search - tctmd.com

Displaying 321 - 340 of 492

Sort: Relevancy | Date

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Daily News

Cannabis Abuse Linked to Periprocedural MIs After Elective Surgeries

Shelley Wood

December 03, 2019

News Daily News

Physicians as Patients: Better Health, Less CV Prevention Among Ontario Doctors Than General Public

Yael L. Maxwell

November 26, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Daily News

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

Caitlin E. Cox

November 04, 2019

News Daily News

Loneliness Linked to Higher Rates of Mortality in Cardiac Patients

Michael O'Riordan

November 04, 2019

News Daily News

Obesity Prevalence Triples in China Over 10-Year Span

Michael O'Riordan

October 28, 2019

News Daily News

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

L.A. McKeown

October 23, 2019

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

L.A. McKeown

October 21, 2019

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News HFSA 2019

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

L.A. McKeown

September 24, 2019

News Conference News HFSA 2019

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

L.A. McKeown

September 23, 2019

News Daily News

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

L.A. McKeown

September 13, 2019

News Conference News ESC 2019

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

Yael L. Maxwell

September 10, 2019

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Daily News

Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events

L.A. McKeown

August 30, 2019

News Daily News

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

Todd Neale

August 23, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

Advertisement

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Cannabis Abuse Linked to Periprocedural MIs After Elective Surgeries

Physicians as Patients: Better Health, Less CV Prevention Among Ontario Doctors Than General Public

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

Loneliness Linked to Higher Rates of Mortality in Cardiac Patients

Obesity Prevalence Triples in China Over 10-Year Span

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

Recurrent Events Common Among Young Patients With CAD

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content